戻る Agenda
Special Session-3 : Consider the Future of the Pharmaceutical Industry. ~What value can DIA Create?
Session Chair(s)
Goshi Ozawa, MS
Representative Director & President, Japan / R&D Head
Juniper Therapeutix K.K., Japan
Speaker(s)
Reflections from 3rd DIA Community Day - Current tasks and what can be done with DIA
Noriaki Nagao, MPharm, PMP
JAPAN TOBACCO INC., Japan
Pharmaceutical Division,Clinical Development Dept.
Horizon Scanning from 2040; Discussion at DIA Cutting Edge #1
Keita Asato, MBA, PMP
Amgen K.K., Japan
Senior Medical Advisor, Development TA (General Medicine), Medical Development
Kotone Matsuyama, RPh
Nippon Medical School, Japan
Professor, Department of Health Policy and Management
Yukihiro Matsuda, MSc
ICON Clinical Research GK, Japan
Director, Clinical Delivery
Sonoko Misawa, MD, PhD
Chiba University Graduate of Medicine, Japan
Associate Professor, Department of Neurology
Akira Nakanishi
Century Medical,Inc., Japan